Thursday, July 23, 2026

Thread Lifts in Your 20s? Why Gen Z Is Getting a Head Start on Aging

Interest in slow aging rises among young adults, leading to increased thread-lifting procedures for skin rejuvenation and elasticity.

The $2 BILLION Snub: Trump Dumps Denuclearization for a Photo-Op, Only to Be Humiliated By a Richer Kim Jong Un

Trump seeks to meet Kim Jong Un, but North Korea remains reserved, requiring clear benefits before engaging in dialogue.

AI MIDDLE EAST LIFELINE: Is The Tesla CEO Betting On Saudi Arabia To Save The AI Dream?

Musk and Huang discussed AI advancements at the U.S.–Saudi Investment Forum, alongside major CEOs and President Trump addressing key sectors.

Jeong Eun Kim

Author's Latest

Bukwang Pharma Wins Phase 3 Approval to Expand Latuda Into Adjunctive Treatment for Major Depression

Bukwang Pharmaceutical received approval for a Phase 3 clinical trial of Lurasidone as an adjunctive treatment for MDD.

JNPMedi Secures ISO 13485 Certification, Strengthening Its Medical Device Consulting Credibility

JNPMedi has achieved ISO 13485 certification, enhancing its quality management for clinical research and regulatory consulting in medical devices.

Daewoong’s Envlo Matches Established SGLT-2 Drugs in Landmark Head-to-Head Diabetes Study

Daewoong Pharmaceutical's Envlo shows promising results in diabetes treatment, comparing favorably to existing SGLT-2 inhibitors in a clinical study.

Sam Chun Dang Pharm Wins EMA Approval for Phase 1 Trial of Oral Insulin Candidate SCD0503

Samchundang Pharmaceutical's oral insulin candidate 'SCD0503' received final approval for Phase 1 clinical trials from EMA.

Celltrion Moves CT-G32 Into Final Preclinical Stage as Global Obesity Trial Preparation Accelerates

Celltrion advances CT-G32, a next-gen obesity treatment, targeting multiple pathways to enhance weight loss while preserving muscle mass.

Metavia Highlights Strong Early Weight-Loss Data for DA-1726 at EASL 2026

MetaVia's obesity treatment candidate 'DA-1726' shows safety and weight loss effects in Phase 1 trials after 54 days.

Daewoong Pharmaceutical Partners With Seers and TR to Develop Integrated Smart Ward Respiratory Care Solution

Daewoong Pharmaceutical signed an MOU with Cears and TR for the expansion of digital healthcare solutions.

HLB to Spotlight Liver and Bile Duct Cancer Pipeline at ASCO 2026 With Standalone Global Booth

HLB will showcase liver cancer drug candidates at ASCO 2026, including promising combination therapies and precision medicine studies.

Lunit to Present Five AI Biomarker Studies at ASCO 2026 Highlighting Expanded Clinical Applications

Lunit will present five AI studies at ASCO 2026, showcasing biomarker analysis for cancer treatment and patient response prediction.

South Korea Expands HPV Vaccination Program to 12-Year-Old Boys as Experts Stress Broader Cancer Prevention

HPV vaccination now includes 12-year-old boys in South Korea, addressing rising infection rates and promoting awareness for both genders.

AstraZeneca Highlights Decade of Tagrisso Progress in EGFR Mutation-Positive Lung Cancer Care

Tagrisso has revolutionized NSCLC treatment in Korea, expanding indications and improving survival rates over the past decade.

Huons Meditech Secures CE-MDR Certification for Premium 9-Pin Needle Ahead of European Expansion

Huons Meditech secures CE-MDR certification for its Premium 9-Pin Needle, enhancing its European market entry and global expansion strategy.

NCCN Adds Imaging-Based Breast Cancer Risk Assessment, Opening New Path for AI Screening Tools

Lunit's AI tool for breast cancer risk assessment gains recognition in NCCN guidelines, enhancing early detection and personalized management.

Growing Demand for Brain Supplements Raises Concerns Over Delayed Dementia Diagnosis

As Family Month approaches, experts warn against relying on dietary supplements for memory issues, urging timely medical evaluations instead.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.